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CT.
Sepsis has historically been categorized into discrete subsets based on expert
consensus-driven definitions, but there is evidence to suggest it would be better
described as a continuum. The goal of this study was to perform an exhaustive search
for distinct phenotypes of sepsis using various unsupervised machine learning
techniques applied to the electronic health record (EHR) data of 41,843 Yale New Haven
Health System emergency department patients with infection between 2013 and 2016.
Specifically, the aims were to develop an autoencoder to reduce the high-dimensional
EHR data to a latent representation amenable to clustering, and then to search for and
assess the quality of clusters within that representation using various clustering
methods (partitional, hierarchical, and density-based) and standard evaluation metrics.
Autoencoder training was performed by minimizing the mean squared error of the
reconstruction. With this exhaustive search, no convincing consistent clusters were
found. Various clustering patterns were produced by the different methods but all had
poor quality metrics, while evaluation metrics meant to find the ideal number of
clusters did not agree on a consistent number but seemed to suggest fewer than two
clusters. Inspection of one promising arrangement with eight clusters did not reveal a
statistically significant difference in admission rate. While it is impossible to prove a
negative, these results suggest there are not distinct phenotypic clusters of sepsis.
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Introduction
Sepsis, defined as “life-threatening organ dysfunction caused by a dysregulated host
response to infection” (1), affects an estimated 30 million people worldwide every year,
potentially resulting in 5.3 million deaths annually (2). In one 2017 study of 409
hospitals encompassing 10% (2,901,019) of all hospital admissions in the United States,
the incidence of sepsis was 6.0% with a mortality rate of 15% (3). Another study of two
large cohorts including nearly 7 million adult hospitalizations in the United States
between 2010 and 2012 found that sepsis contributed to between 34.7% and 55.9% of
all inpatient deaths (4). According the Agency for Healthcare Research and Quality, in
2013 sepsis was the most costly condition in the United States, responsible for 23.6
billion dollars of healthcare expenditure that year alone. That expense amounts to 6.2%
of national hospital costs resulting from nearly 1.3 million hospital stays (5). These
staggering statistics are why in 2017 the WHA, the decision-making body of the WHO,
adopted a resolution declaring the importance of improving diagnosis and management
of sepsis (6), and why in 2018 there were more than 2,300 publications mentioning
sepsis in the title when searched via PubMed.

Sepsis Definitions
Despite the interest in and impact of sepsis, it remains poorly understood. Its etiology is
likely multifactorial, dependent upon both host and pathogenic factors, pro- and antiinflammatory mediators, and the coagulation and neuroendocrine systems (7). But
lacking a precise understanding of its pathophysiological mechanism, the task of
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defining the syndrome has been left to expert-led consensus groups which have
reviewed and revised their recommendations three times since 1991 with no shortage
of controversy (1, 8-11).
While terms like “sepsis syndrome” were proposed earlier by researchers like Bone et
al. in a 1989 trial of methylprednisolone for sepsis (12), the first consensus-based sepsis
definitions were proposed at the 1991 American College of Chest Physicians/Society of
Critical Care Medicine Sepsis Definitions Conference and published in 1992 (13, 14).
Those definitions differentiated between infection, the invasion of host tissue by
microorganisms, from sepsis, defined as the systemic host response to that infection as
identified by having greater than one of the Systemic Inflammatory Response (SIRS)
criteria (8). The SIRS criteria, which had been previously defined and which even then
were acknowledged as not specific to sepsis, were composed of: 1) a temperature
greater than 38°C or less than 36°C; 2) tachycardia greater than 90 beats per minute; 3)
tachypnea greater than 20 breaths per minute or a PaCO2 of less than 32 mm Hg; and 4)
a white blood cell count greater than 12,000/mm3 or less than 4,000/mm3, or the
presence of more than 10 percent immature neutrophils. The experts proposed the
term “severe sepsis” to define the pathological condition where the adaptive response
known as sepsis became maladaptive by causing organ dysfunction, hypoperfusion
(lactic acidosis, oliguria, or acutely altered mental status), or sepsis-induced
hypotension. They further defined “septic shock” as a more extreme subset of “severe
sepsis” where the maladaptive response produced fluid-unresponsive hypotension or
tissue hypoperfusion. Although the consensus group explicitly acknowledged that
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“sepsis and its sequelae represent a continuum of clinical and pathophysiologic
severity”, they also defined transition points between these states which were
subsequently used for nearly two decades to guide patient care and recruitment into
clinical trials. Infection was differentiated from sepsis by two or more SIRS criteria; the
adaptive host response (sepsis) became maladaptive (severe sepsis) with the presence
of organ dysfunction, hypoperfusion, or hypotension; and fluid unresponsive
hypotension marked the transition point between severe sepsis and septic shock.
The 1992 definitions were criticized almost immediately. The use of the SIRS criteria was
criticized for its rigid cutoffs that narrowly excluded potentially septic patients from
clinical trials, its lack of specificity for sepsis and the consequent heterogeneity of the
patients it captured (68% of one study group including ICU and general wards patients
met SIRS criteria), its uselessness for guiding clinical care, and its superficial relationship
with underlying pathophysiology (10, 15).
In response to these criticisms, in 2001 a second sepsis definitions conference was held.
However, citing a lack of new evidence, the expert consensus group merely reaffirmed
the 1991 definitions with the additional acknowledgement that more clinical and
laboratory variables could be used to identify systemic illness than just the four SIRS
criteria. They did not provide specific guidance about how to use these additional
variables to make the diagnosis (9).
Over the subsequent decade, the same criticisms of the definitions persisted and new
studies clarified existing shortcomings. More researchers pointed out the need for
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objective principles and biomarkers (16), while others suggested that organ dysfunction
become part of the criteria for sepsis to prevent confusion between the terms sepsis
and severe sepsis (17). Significantly, in 2015 Kaukonen et al. showed that among more
than 100,000 ICU patients with infection and organ failure, one in eight did not meet
SIRS criteria and mortality increased in a linear stepwise fashion with each additional
SIRS criterion. There was no transitional increase in mortality at the threshold of two
SIRS criteria, challenging “the sensitivity, face validity, and construct validity of the rule
regarding two or more SIRS criteria in diagnosing or defining severe sepsis in patients in
the ICU” (18).
Finally, in 2016 a group of critical care specialists met once more to develop the Third
International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). The task force
determined that limitations of previous definitions included “excessive focus on
inflammation, the misleading model that sepsis follows a continuum through severe
sepsis to shock, and inadequate specificity and sensitivity of the systemic inflammatory
response syndrome (SIRS) criteria” (1). They created the current definition for sepsis,
“life-threatening organ dysfunction caused by a dysregulated host response to
infection,” and operationalized this definition as the increase of two or more points in
the ICU-centric Sequential Organ Failure Assessment (SOFA) score. Severe sepsis was
discarded as a redundant term, and septic shock was defined as a higher-mortality
subset of sepsis in requiring vasopressors to maintain a mean arterial pressure of 65 mm
Hg or greater and a serum lactate level greater than 2 mmol/L (>18 mg/dL) in the
absence of hypovolemia. The consensus article and two accompanying analyses
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determined the in-hospital mortality rates of these new definitions to be greater than
10% for sepsis and greater than 40% for septic shock (19, 20). The group also published
a new scoring system, the quick Sequential Organ Failure Assessment (qSOFA) score,
meant to be used to identify patients with a mortality equivalent to that of sepsis
outside the ICU setting.
While the most recent criteria were analyzed with data in the papers that accompanied
their release, they were still expert consensus-based and not derived a priori from an
understanding of the pathophysiology (21). The group did not delineate distinct
phenotypes of patients within the heterogeneous group captured by the non-specific
organ dysfunction criteria. Moreover, they retained a categorical distinction between
normal physiology, sepsis, and septic shock with discrete laboratory and clinical cutoffs.
This categorical approach has been criticized as far back as the early literature prior to
the release of the first sepsis definitions. In their 1992 critique of Bone et al.’s proposed
“sepsis syndrome” definition, Knaus and colleagues wrote of their own analysis: “these
findings led us to our major conclusion that while categoric definitions of sepsis may be
useful in selecting patients for entry into clinical trials, they may not be useful in
characterizing individual, or perhaps even group, risks. What our results suggest rather
is that the current clinical condition of sepsis, at least as it is applied to a subset of
critically ill patients admitted to ICUs, is a continuous state with the prognosis
determined, in large part, by the degree of physiologic imbalance at the time of
admission” (22).
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This debate over definitions has significant real-world implications for patients because
definitions can drive management. One of the major turning points in the management
of sepsis was the 2001 trial of early goal-directed therapy (EGDT) for severe sepsis and
septic shock, frequently referred to as the Rivers trial after its first author (23). The trial
showed that when severe sepsis or septic shock were managed with specific goals for
central venous oxygen saturation and pressure, hematocrit, and mean arterial pressure,
mortality dropped from 46% to 30% compared to standard of care. The intervention
was validated in a population of patients meeting severe sepsis and septic shock criteria
as determined by the 1992 consensus definitions (two or more SIRS criteria with
hypotension or elevated lactate). More contemporary trials of EGDT for septic shock
have also used as entry criteria two SIRS criteria with refractory hypotension or elevated
lactate (24). Since interventions validated in clinical trials are often applied only to the
validated patient population, and in light of recent findings describing the stepwise
linear increase in mortality with each additional SIRS criterion and the lack of a major
transitional increase in mortality with two SIRS criteria, there may have been many
patients that could have benefited from trial-validated interventions but did not receive
them.
Based on all this prior work and debate, it stands to reason that if smaller groups of
distinct pathophysiological processes or phenotypes could be identified amongst the
heterogeneous group captured by expert consensus-defined diagnostic criteria, we
might better be able to discover and deliver effective interventions. That is the
motivation of this thesis.
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Machine Learning and Electronic Health Records
The advent of widespread use of electronic medical records has created significant
opportunities for large-scale data mining in healthcare (25). The sheer quantity of data
available makes it amenable to analysis with a set of statistical inference algorithms
known as machine learning.
Machine learning techniques applied to electronic health record data provide a
potential solution to the problem of sepsis categorization by enabling phenotype
discovery without the manual selection of features. The realm of machine learning is
generally divided into two types of learning algorithms: supervised and unsupervised.
Supervised learning aims to make predictions from data with a model trained on
examples where the predicted value is known. Data where the target variable is known
is called labeled data. A well-known example of a supervised task is the identification of
objects within an image. To make accurate predictions, these models are trained on
images where the object within the image has already been labeled.
On the other hand, unsupervised machine learning aims to discover patterns in data
that has no labels (26). There are several types of unsupervised learning tasks, but one
of the most common is called clustering, which is the attempt to separate unlabeled
data into distinct clusters so that similar instances are grouped closely in space.
Clustering techniques can be broadly be divided into hierarchical and partitional
methods. Hierarchical methods function by creating a nested series of partitions,
forming a dendrogram, whereas partitional methods only have one high-level partition
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(27). Whatever the method, clustering applied to electronic medical record data
provides an opportunity to discover distinctly different subsets of patients and disease
states that are more similar to each other than they are to those in other clusters. This
categorization can enable prediction and risk-stratification, can inform development of
future therapies, and has even been used to discern subtypes of sepsis (28-32).
One of the challenges of applying clustering techniques to EHRs is that the data is very
high-dimensional, has frequently missing values, and is highly heterogeneous combining
both continuous and categorical variables (33-35). Traditional clustering techniques, like
the k-means algorithm, do not perform well on very high-dimensional data. Thus, prior
to clustering, high-dimensional data is often reduced to fewer dimensions using
techniques that try to preserve the high dimensional relationships in a lowerdimensional latent space. Principle component analysis is an oft used method that
attempts to find a transformation of the variable space that accounts for the variance
within the distribution of data with the fewest possible orthogonal dimensions, known
as principal components. More recently however, the development of a type of deep
learning called the autoencoder has provided a more robust method for dimensionality
reduction that is ideally suited for EHR data due to its ability to “learn” highly abstract
features which can be represented in fewer dimensions (36).
Deep learning is a relatively new field that loosely emulates the structure neurons in the
human brain – an “artificial neural network” -- to create computational models that
learn abstract representations of data (37). They offer multiple advantages over more
traditional learning algorithms, one of which is their ability to model complex non-linear
13

functions. Deep learning is responsible for numerous breakthroughs in computer vision,
speech-to-text transcription, and even self-driving cars.
Invented by one of the fathers of artificial neural networks, Geoff Hinton, autoencoders
are a type of deep learning where the input data is sequentially forced to be
represented in fewer and fewer dimensions with each layer of the network before being
allowed to expand again to the original number of dimensions with an architecture
mirroring the reducing side. The network is then optimized so that the error between
the input data and output data, known as the reconstruction error, is minimized. Once
training is complete, new data can be fed through the first half of the network, the
encoder, which outputs a latent representation that can subsequently be used for
clustering. Essentially, the data is forced through a bottleneck that acts to compress the
representation of the high dimensional data into fewer dimensions with minimal loss
(38). Already, this technique has been applied to gain new insights from EHR data,
including diagnosis prediction and the imputation of missing data (39, 40). These recent
advances, from EHRs to machine learning and deep learning, provide researchers with
powerful new tools to gain novel insights that could help patients.
In this thesis, I perform an exhaustive search for distinct phenotypes of infection by
applying various clustering techniques to the latent (i.e. low-dimensional)
representation of EHR data. If clusters can be identified within the data and these
clusters have distinct features and mortalities, they could enable more precise clinical
management and inform future investigations into targeted therapeutic approaches. If,
however, an exhaustive search fails to reveal clusters, it would support the notion that
14

sepsis exists as a continuum and thus ought to be treated as such in clinical
management. For example, a computer model that could project likelihood of inhospital mortality might enable more precise clinical management than the current
categorical classification of simply sepsis or septic shock. This effort is motivated by the
aforementioned shortcomings of the expert-defined sepsis definitions, namely their use
of cutoffs within continuous variables such as respiratory rate; their limitation to a small
number of variables amenable to bedside rules; their muddied purpose of both clinical
trial inclusion criteria and framework for clinical management; and ultimately their
categorical classification of mortality despite the evidence for a continuum of disease
severity (18, 22).

Aims
The purpose of this thesis is to perform an exhaustive search for clusters corresponding
to distinct phenotypes of infection within the EHR data of patients in the emergency
department with infection. I hypothesize that no clusters will be found. Because
machine learning has a degree of art to it in addition to science, there is no way I can
definitively prove that clusters do not exist; what I aim to do is to try multiple
approaches to reasonably demonstrate that such clusters are unlikely.
Thus, my specific aims are the following:
1. Develop an autoencoder to reduce the high-dimensional EHR data to a latent
space amenable to clustering while minimizing reconstruction error.
2. Use multiple partitional and hierarchical clustering methods to cluster the data.
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3. Evaluate the proposed clusters with a variety of cluster validity metrics.

Methods
Study Design
This was a retrospective study of ED visits to three Yale-New Haven Health System
(YNHHS) emergency departments between March 1, 2013 and May 1, 2016. The study
was approved by the institutional review board.

Study Setting and Population
This study was performed across three sites: 1) the YNHHS York Street ED, 2) the YNHHS
Saint Raphael ED, and 3) the YNHHS Shoreline ED. All hospitals used the Epic ASAP
(Verona, WI) EHR.
This study included all emergency department encounters with patients at least 18
years old having a primary encounter diagnosis considered to be of infectious etiology,
determined by ICD-10 code membership in a list of predetermined “infectious” ICD-10
codes. In order to include all patient encounters that were potentially septic, I reviewed
all ICD-10-CM codes and generated a list of codes corresponding to diagnoses that could
elicit a host response to infection. The decision to include or exclude a certain diagnosis
was made based on my thesis advisor’s and my clinical knowledge of the potential for
that diagnosis to lead to sepsis. So, for example, “appendicitis” was included while
“acute tubulo-interstitial nephritis” was not. Each included diagnosis was further
categorized as one of the following types: “bacterial”, “viral”,
“fungal/protozoal/parasitic”, or “unspecified”. The “unspecified” category was applied
16

when the diagnosis description was insufficient to determine the type of infectious
process, e.g. “Pharyngitis”, or when the infection was specifically labeled as of
unspecified origin, e.g. “Pneumonia, unspecified organism”. It was additionally found
that because the study timeframe included the transition from the ICD-9 to the ICD-10
standard, certain diagnoses within the Yale-New Haven Health System’s Epic
deployment lacked an ICD-10 code but possessed an ICD-9 code. In order to capture
patient encounters associated with these diagnoses, I broadened the inclusion list to
include any diagnoses where there was both no ICD-10 code and one of the following
conditions were met: 1) the ICD-9 code was explicitly for an infectious or parasitic
disease (ICD-9 001-139) or 2) the diagnosis name (as listed in the Epic deployment’s
table) contained one of several keywords I defined, e.g. “infectious” or “cellulitis”. These
additional diagnoses were also further categorized as with the ICD-10 codes.
I was motivated to cast a wide net with any potentially “infectious” ICD-10 codes rather
than using physician-diagnosed sepsis in order to avoid biasing the included population
towards those that met consensus-defined criteria. The objective was to capture all
potential phenotypes of sepsis, including those that may have yet been unknown.

Study Protocol
An overview of the study protocol can be seen below in Fig. 1. Briefly, data was
extracted from the EHR and reduced to one measurement per variable per encounter
within a four-hour window starting with the first recorded measurement of any type for
that patient. The data was then limited to only include variables not more than 50%
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missing with the exception of a few that are part of the SOFA or septic shock criteria
which I was motivated to retain due to prior work showing their importance in sepsis
mortality prediction. Values were then imputed for all missing values. For each variable,
an additional binary variable was added designating whether the value had been
imputed or not. The now-complete dataset with 41,843 encounters and 290
variables/dimensions was used to train an autoencoder that compressed the dataset to
a latent space of 16 dimensions. This compressed dataset was then used as the input for
various clustering techniques which were subsequently evaluated. With the exception of
the initial SQL query, all data analysis and autoencoder training was performed with the
Python programming language with Jupyter notebooks. The Python packages Pandas,
Sci-kit Learn, Keras with Tensorflow were used extensively for the data processing,
clustering, and deep learning respectively. A detailed explanation follows below.
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Fig. 1: Overview of the study protocol. Starting in the top left: rows and columns of data with some missing values
(black) are restricted to only include columns without overly-missing data. The remaining missing data is imputed
(all white), and then is used to train the autoencoder. When the autoencoder is trained, the encoding layers are
extracted and used to generate a compressed representation of the data that is amenable to clustering.

Data Set Creation
All data was extracted from the Clarity enterprise data warehouse (Epic) with Structured
Query Language (SQL) queries. For each patient encounter, these queries extracted
demographic information (age, sex, ethnicity), social history (smoking status, alcohol use
status, illicit drug use status), vital signs and oxygen requirement while in the ED, labs
obtained in the ED, home medications, and past medical history.
Encounters missing disposition (1,146) were removed leaving a total of 41,843
encounters. Ages above 115 were converted to missing (NA) because 116 is the age
used in Epic for unidentified patients.
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For social history, if more than one response was recorded for a patient (e.g., smoking
list as never smoker and every day smoker), the more severe value was chosen because
it is less likely that was entered in error.
Past medical history for each patient was extracted in the form of ICD-10 code. In order
to group the numerous possible diagnoses into meaningful and relevant abstract
categories, each ICD-10 diagnosis was mapped to categories defined by the AHRQ
Clinical Classification Software (CCS). For each encounter, this list of retained CCS codes
was limited to those determined by my thesis advisor and me to affect the immune
response. This determination was made by consulting various clinical scoring systems
(SOFA, APACHE II/III, Charlson comorbidity score) and individual parameters used for
sepsis criteria or sepsis mortality prediction (1, 19, 41-47). Finally, the list of CCS codes
was condensed to form a more abstracted list of 17 classes of relevant past medical
history (Error! Reference source not found.). Ultimately, each encounter was associated
with 17 binary values, each indicating the presence of one of the types of relevant past
medical history.
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Table 1: Past medical history categories
HIV infection

Cancer

Immunity disorders

Maintenance chemotherapy or radiotherapy

Asthma

Chronic obstructive pulmonary disease and bronchiectasis

Other Respiratory

Liver disease (alcohol-related)

Thyroid disorders

Kidney disease

Diabetes

Other nutritional, endocrine, and metabolic disorders

Arrhythmias

FEN (electrolyte and nutritional disorders)

CHF

Hypertension with complications and secondary hypertension

Heart Disease

Similarly, patient home medications were grouped into categories based on the YNHHS
medication type schema. There were a total of 48 types of medication classesError!
Reference source not found., and as with past medical history, each patient encounter
was associated with 48 binary values, each indicating whether the patient was using one
or more medications of that class. An additional variable was added to each encounter
which corresponded to the total number of home medications in order to add additional
information to the otherwise binary encoding.
In developing the “number of medications” variable, it became apparent that this
section of the EHR may be particularly prone to user error or infrequent updating since
many patients were using an inordinately large number of medications (Fig. 2). It is also
possible that our SQL query failed to distinguish between active medications and ones
that the patient was no longer using. Rather than decide upon an arbitrary cutoff for
what a reasonable number of medications is, I decided to leave it as is with the
understanding that if it is particularly noisy or meaningless, it will be deemphasized in
the latent space representation after passing through the autoencoder.
21

Fig. 2: Distribution of number of home medications. Note the logarithmic scale.

Laboratory values and vital sign measurements required a different approach. Whereas
the other data, like demographics or medications, only had one allowable value per
encounter, vital signs and laboratory values could be measured multiple times. With the
motivation to try to capture phenotypes as they initially presented without the
influence of therapeutic intervention, we chose to limit labs and vitals to those recorded
within a few hours of arrival to the emergency department. On the one hand, if the time
window was too short we risked losing valuable data that was reported later (e.g., a lab
that was drawn early in the visit but had not been reported by the laboratory until
several hours later). On the other hand, too long a window risked retrieving labs and
vitals that had been influenced by therapeutic interventions. To determine an ideal time
window, I examined the fraction of common labs and vitals missing as a function of time
since arrival. The point at which the curve begins to flatten is the point at which
extending the window does not provide substantially more data to warrant inclusion of
biased values (Fig. 3). Ultimately, I decided that four hours produced a reasonable
tradeoff since extending beyond that did not appreciably decrease the amount of
missing data.
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Fig. 3: Percentage of data missing as a function of time since first data point. This plot illustrates the effect of
different time window cutoffs on the percentage of data available. Too short a cutoff results in a lot of missing
data.

Since vital sign observations are manually entered by nursing staff, one can expect
aberrant values and nonsensical outliers. It becomes more difficult to discern real values
from mistakes when the data entered is theoretically possible, but improbable (e.g. a
systolic blood pressure of 300). To try to limit the effect of outliers on vital signs data, I
tried a number of techniques commonly used for dealing with outliers. Limiting vitals to
three standard deviations of the mean proved too restrictive; the distribution of healthy
vital signs is so narrowly distributed that even aberrant values seen commonly in the
emergency department (e.g., a heart rate of 144 beats per minute) would have been
excluded. I then attempted to limit vitals to 1.5 and 3.0 times the interquartile range
(IQR) above the third quartile and below the first quartile, which are common
definitions of outliers and extreme outliers. This method also proved too limiting as it
discarded values like a respiratory of 28 as an extreme outlier. Distributions of vital signs
are shown as boxplots in Fig. 4.
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Fig. 4: A boxplot of the distribution of vital signs. gcs = Glasgow Coma Score, hr = heart rate, o2_amount = oxygen
requirement (L/min), o2_sat = SpO2, rr = respiratory rate, temp = temperature (f), sbp = systolic BP (mm Hg), dbp =
diastolic BP (mm Hg).

Ultimately, the best solution was to limit the vital signs to estimated physiological limits
based on the experience of my thesis advisor and an examination of the values listed
(e.g., a respiratory rate above 70 is more likely to be a heart rate entered in the wrong
field than a respiratory rate. Table 2 below shows the cutoffs that were used for each
vital sign. Values greater than the maximum or less than the minimum were set as
missing values (NA).
After clipping vitals, most encounters had multiple values for each vital sign recorded
during the four-hour time window. In order to reduce these observations to a single
observation per encounter, vital summary statistics were creating. For each vital sign, a
new variable was generated corresponding to the first, last, minimum, mean, and
maximum values during the
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Table 2: Cutoffs for vital signs
Vital sign
Glasgow coma scale
Heart rate
Respiratory rate
Temperature (F)
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
Oxygen amount (L/min)
Oxygen saturation (SpO2)

Min
0
30
8
80
30
20
0
40

Max
15
300
70
110
300
250
60
100

time window. Another vital sign not shown in Fig. 4 or Table 2 is the oxygen dependency
status. This was a categorical variable based upon a free-text field that required coercing
into a limited number of possible options. These final categories, in order of increasing
demand, were room air, other, nasal, mask, positive pressure, and mechanical
ventilation. Since this variable was categorical instead of continuous, the mean
summary statistic was replaced with the mode statistic.
Laboratory values were extracted only if the result was posted within the four-hour time
window. If more than one measurement was posted for a given lab within that
timeframe, only the first value was extracted in accordance with the goal of having a
snapshot of the patient before therapeutic interventions influenced measurements. Any
laboratory tests that had not posted a result in the four-hour time window were marked
as missing (NA).
After windowing was complete, the degree of missing data was assessed. To avoid
creating a dataset that was overall greater than 50% missing, I chose to retain only
variables less than 50% missing with the exception of variables that feature prominently
in the SOFA score or sepsis definitions (e.g., bilirubin and lactate).
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The full list of labs that were retained and the percentage missing in the full dataset is
listed in Table 6 in the appendix.
Imputation
After all the data was merged together and there was only one value per variable per
encounter, missing data was addressed by imputing the column mode for each variable.
Both mean and mode imputation were considered, but many of the variables, especially
vitals and labs, were distributed in Poisson distribution with long tails towards abnormal
values. Choosing mean imputation in these cases would have unreasonably skewed the
imputation towards abnormal values. For example, lactate would have been imputed
with a value greater than 2 mmol/L, which is greater than the threshold for inclusion in
the septic shock criteria with the Sepsis-3 definitions.
In addition to imputing the mode, for each variable an additional column was added to
mark with it was missing or not. The intent was for the autoencoder to learn to
associate the missing marker with the missing variable itself and thus learn to ignore or
discount that imputed variable.
Autoencoder Training
To make the dataset amenable to consumption by a neural network, all variables had to
become numeric. Any Boolean variables (e.g., “uses alcohol”) and categorical variables
(e.g., “O2 dependency” which could be room, nasal, etc.) were one-hot encoded. Onehot encoding transforms a single column of categorical values into a binary matrix
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where each column corresponds to a single category and the binary value marks
whether this category is present or not.
The data was then randomly split into a training (90%) and validation set (10%). One of
the risks of training a machine learning model is overfitting the training data so that the
model “memorizes” the training data but generalizes to new data poorly. To evaluate
the model’s generalizability, which is also a proxy for the degree to which it is learning a
meaningful latent representation of the input data, the model is trained on one set of
data but evaluated on another (48).
After splitting, each variable was zero-centered and scaled to unit variance by
subtracting the mean and dividing by the standard deviation. This is common practice
because many machine learning estimators behave badly if individual features do not
resemble normally distributed data. One can imagine that if one feature had
significantly more variance than another, it would dominate training because it would
have more proportional explanatory power of variance compared to other variables
(48).
With the data prepared ready for training, the next task was to find a combination of
autoencoder parameters which, after training, would produce the lowest reconstruction
error on the validation set. For this purpose, reconstruction error was measured as the
mean squared error between the autoencoder input and output. A total of 16 encoding
dimensions was chosen from the set of [2 8, 16, 32] because initial experiments training
on a small subset of the data showed that 16 dimensions produced an acceptable
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tradeoff between reconstruction error and a small enough number of dimensions to be
easily amenable to clustering. A useful comparison is the dimensionality reduction from
PCA. PCA applied to the dataset showed that 119 dimensions were required to explain
95% of the variance, so the autoencoder should at least be able to reduce the number
of dimensions to 119 without much loss. For further comparison, I took the first 2, 4, 8,
16, and 32 principal components and projected the dataset into each and then reversed
the transformation to create a lossy reconstruction from the compressed data. The
reconstruction error from each of these compressed representations served as a useful
benchmark for comparing to the autoencoder. If the autoencoder is “learning” an
abstract representation of the data, it should outperform PCA when encoded with the
same number of dimensions. I examined the difference in reconstruction error between
PCA and a prototype of the autoencoder for the same number of compressed
dimensions and observed where the difference between reconstruction errors began to
stabilize (Fig. 5 and Fig. 6). This occurred around 16 dimensions, validating this choice.
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Fig. 5: Reconstruction mean-squared error (mse) as a
function of # compressed dimensions with a prototype
autoencoder (AE) and PCA.

Fig. 6: Difference in reconstruction mean-squared error
between PCA and autoencoder (AE). The curve flattens
between 8 and 16 dimensions, suggesting diminishing
benefit of AE over PCA beyond 16 dimensions.

After deciding on the number of encoding dimensions, I varied the network architecture
(number of layers, number of neurons per layer), the optimizer and its learning rate
(Adam and Adadelta), and various regularization parameters which serve to prevent
overfitting (L2 normalization, batch normalization, and dropout)(48, 49). Ultimately, the
combination that had the lowest reconstruction error on the validation set was an
architecture with 2048-1024-512-16-512-1024-2048 neurons in each layer, with the 16neuron layer serving as the encoding layer. The ideal optimizer was the Adam optimizer
with a learning rate of 0.0001, and the network was trained with a batch size of 4096
training examples per batch. To prevent overfitting, the ideal input dropout rate was 5%
with a dropout rate of 20% between hidden layers except between the encoding layer
and the subsequent 512-neuron layer, along with batch normalization. After training for
1700 epochs the validation loss began to climb signifying overfitting, so training was
halted and the best scoring model was saved and used for all future work. When the full
dataset was put through the autoencoder and compared to its reconstruction (this time
without the effect of dropout), the network produced a reconstruction error of 0.118,
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which compares very favorably to the PCA reconstruction mean-squared error for the
same number of dimensions (a total of 16), which was 0.419.
Clustering
Once the autoencoder was trained, the entire original dataset was transformed via the
encoder to its latent 16-dimensional representation. From this point, an exhaustive
search was performed with various clustering algorithms. For each algorithm attempted,
several cluster validation metrics were applied to analytically determine cluster fit, and
the clustering results were visualized in 2-dimensional PCA and t-SNE transformations of
the latent space to permit visual assessment of cluster fit. The t-SNE algorithm is a nonparametric mapping algorithm used to project higher dimensional data into lower
spaces while preserving higher-level relationships between points (50). The clustering
methods attempted were k-means, agglomerative hierarchical clustering with multiple
distance metrics (linkages), and the density-based DBSCAN algorithm. Prior to any
clustering, the overall propensity for cluster-ability was assessed by projecting the
original and latent data into 2 dimensions with PCA and t-SNE, as well as by calculating
the Hopkins statistic (51) which returns values greater than 0.5 when the data is
clumped. It does not differentiate between data that is in one big cluster versus several
smaller clusters.
After clustering, the fit of each cluster arrangement and number of clusters was
assessed with the elbow method (52), silhouette score (53), gap statistic (54), Calinski
and Harabasz score (55) where possible.
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Results and Discussion
Quality of dimensionality reduction and latent representation
The PCA two-dimensional projection of the latent representation can be seen in Fig. 7.
While the PCA projection of the latent features does not contain any visually discernable
clusters, because it is such a compressed representation it may certainly have a
structure that is just not captured in two dimensions. Another way to visually assess the
presence of distributions amenable to clustering within data of greater than a few
dimensions is to plot a histogram of the distributions along the primary principle
components of the latent space (Fig. 9). With the exception of some secondary peaks in
the third and fifth principal components, there are no obvious separate distributions
outside the primary Poisson and Gaussian distributions. On the other hand, the t-SNE
projection shows some very distinct clustering. It is important to note t-SNE does not
have any linear relationship to the dimensions that it represents. Rather, it is a mapping
that is learned from the higher dimensional space while optimizing for representing
differences between groups of points in that space.

Fig. 7: PCA projection of the first 2 principal components
of the 16-dimensional latent space produced by the
autoencoder.

Fig. 8: t-SNE projection of the latent space.
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Fig. 9: PCA projection of the first 12 principal components of the latent representation, shown with a logarithmic
scale to better visualize smaller groups. Together these components explain 91% of the variance in this space.

Clustering
Assessing clustering propensity
Prior to clustering, the propensity for the data to form clusters was analyzed. This can
be predicted with a Hopkins statistic (51, 52), which compares the distribution of the
data to what one would expect from a uniformly distributed dataset within the feature
space. Values closer to one indicate that the data is aggregated whereas a value of 0.5
indicates the data is uniformly distributed. The Hopkins statistic for the latent feature
space was 0.94 suggesting it is highly aggregated. The disadvantage of the Hopkins
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statistic is that aggregation does not imply useful clustering because one single large
clump would also have a very high Hopkins statistic.
Assessing ideal number of clusters
To cluster with the k-means algorithm and other partitional clustering algorithms, one
must know the desired number of clusters. A common technique used to provide a bestguess is the so-called elbow method (52). The elbow method plots the sum of withincluster squared distances from each point in each cluster to its cluster centroid. When
there are insufficient clusters, each additional cluster helps lower the sum of withincluster squared distances. But eventually with the addition of too many cluster centers,
they begin to break up preexisting clusters into smaller clusters without a significant
drop in the sum of within-cluster squared distances. The “elbow” in the graph marks this
point of diminishing returns. The elbow method plot for k-means applied to the latent
feature space can be seen in Fig. 10. No elbow is visible, indicating that with k-means
there is not an obviously ideal number of clusters.
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The gap statistic is another widely used method for ascertaining the ideal number of
clusters within a distribution of data (54). The ideal number of clusters is indicated by
the point on the curve where the gap drops for the first time, which is located at 8
clusters in the case of this data (Fig. 11).

Fig. 10: The elbow method plots the within-cluster sum
of squares against number of clusters. A marked bend
in the curve would indicate a point of diminishing
explanatory ability of additional clusters. No elbow is
visible.

Fig. 11: The gap statistic decreases with the addition of
one more cluster to the ideal arrangement, signifying
that the explanatory power of the model is decreasing.
Here, the gap indicates that 8 clusters is ideal.

A third method for evaluating the proper number of clusters is provided by the Calinski
and Harabasz score (55). This score measures the ratio of the between-cluster
dispersion mean to the within-cluster dispersion, so a higher score identifies a model
with better-defined clusters. The Calinski and Harabasz score is shown in Fig. 12 with a
peak score at two clusters and diminishing from there.
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Table 3: Ideal number of clusters, by method
Method (clustering)
Elbow method (k-means)
Gap statistic (k-means)
Calinski and Harabasz (kmeans)
Silhouette score (k-means)

Ideal # of
clusters
N/A
8
2
2

Fig. 12: Calinski and Harabasz score as a function of
number of k-means clusters. A higher score indicates a
better-formed cluster.

In summary, the elbow method did not provide any guidance; the gap statistic,
considered a more standardized version of the elbow method, indicated that eight
clusters would be ideal. On the other hand, the Calinski and Harabasz score indicated
that two (or possibly one, though this is not calculable) is the ideal number of clusters.
Both of these options are examined in the next section. A summary of ideal cluster
number analysis is shown in Table 3. It is important to note that these methods of
clustering propensity are based on clustering with k-means, which is ideally suited for
convex (i.e. spherical) clusters. Thus, the value they provide in identifying ideal number
of clusters is limited to these types of convex clusters.

Partitional Methods
K-means
K-means clustering with anywhere from 2 to 16 clusters was performed and each
arrangement was assessed for quality of fit with the silhouette score (52) which
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measures intra-cluster cohesion against inter-cluster dispersion with a value near one
indicating maximal clustering. The k-means algorithm was repeated for every number of
clusters between two and 15 and the results of the silhouette score were plotted to
assess quality (Fig. 13). Projections of two, five, and eight clusters (as suggested by the
ideal cluster analysis, as well as an intermediate) into two dimensions via PCA and t-SNE
are plotted in Fig. 14. The PCA projection does not provide any new insights; indeed, the
pattern of separation of clusters looks similar to one would expect were one to attempt
to cluster a spherical distribution of points. However, t-SNE projection does seem to
mirror what one might anticipate, especially the 8-cluster arrangement, which nicely
separates the three main groups (colored in red, green, and blue). It is difficult to
reconcile the apparently nice clustering in the t-SNE projection with the lack of other
quantitative evidence in the form of the silhouette score.

Fig. 13: Silhouette score for k-means clustering. A higher
score indicates better cluster separation. Here, the maximum
score is at k=2.
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.

Fig. 14: K-means clustering results in PCA (left) and t-SNE (right) representations with 2 (top), 5 (middle), and 8
(bottom) clusters. Cluster centers are displayed as small white circles in the PCA projections.

However, that does not explain why k-means clustering did manage to align with
splitting of clusters evident in the t-SNE projection. Another interesting observation is
that when only two clusters are utilized, the second cluster is skewed significantly by the
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outliers along the first principal component. This is even more evident in the t-SNE
projection where one can see the second cluster constitutes a very small portion of the
total data points. This could very well be a result of k-means sensitivity to outliers (52).
To address this concern, I also conducted k-medoids clustering in the following section.
K-medoids
K-medoids (also known as Partitioning Around Medoids) is much like the k-means
algorithm except that instead of allowing arbitrary points in space to be the cluster
centers, only actual data points can serve as cluster centers. This mitigates the risk of an
outlier dragging the mean of a cluster far out in one direction and placing a cluster
center far away from most of its points (52). Like k-means, one must specify the number
of clusters k, and it produces convex clusters amenable to analysis with the silhouette
score. With the insight from initial k-means clustering that eight clusters produces nice
separation of the groups in the t-SNE projection, I chose to try k-medoids with eight
clusters. The projections and a silhouette plot are shown in Fig. 15. The mean silhouette
score was 0.008, hardly an indication of good clustering where a score of one is idea.
However, again on t-SNE one can see nice separation of cluster 0, 3, and 6 (red, yellow,
blue) while on PCA it is impossible to discern. It is important to remember that a
limitation of PCA in two dimensions is that much information is lost in the projection to
two dimensions so one cannot say there are not viable clusters just because they are
not appreciable in the projection; in fact, in this case two dimensions only accounts for
41% of the variance. But it is also important to recognize the mapping of points in space
in t-SNE can change based on the hyperparameters chosen for training (perplexity and
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Fig. 15: K-medoids clustering silhouette plot, t-SNE projection, and PCA projection with 8 clusters. The silhouette plot shows the
individual silhouette score of each point in each cluster. Scores closer to 1 indicate good clustering, whereas scores less than 0
indicate poor clustering (i.e. the point does not have more affinity for neighbors in its own cluster than for neighbors in other
clusters). The red vertical dotted line indicates the mean silhouette score (0.008).

number of iterations). While I did do a search of the hyperparameter space to find the
ideally separated groups, it is entirely possible that this mapping is truly representative
of the data in 16 dimensions. I did not appreciate significant changes in the appearance
of the plot as I changed the hyperparameters, but it is possible that another set of
hyperparameters would have produced a mapping less convincing of clusters. In sum,
the t-SNE projection must be taken with a grain of salt. The quantitative methods like
the silhouette score should be trusted in the case where there are convex clusters, and
it is clear that by that metric the ideal number of clusters is two or less. To search for
non-convex clusters, I also tried hierarchical and density-based methods.

Hierarchical Methods
Agglomerative clustering with ward linkage
Agglomerative hierarchical clustering is another approach to clustering altogether,
where the process happens from the bottom up rather than top down. Agglomerative
hierarchical clustering works by successively grouping groups points into a hierarchy of
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trees. In this manner, it may be able to find non-convex shapes of clusters that would
not be found by partitional methods (52). For this implementation, I chose ward linkage
as the minimization objective, which equates to minimizing the variance of two clusters
being merged. Like the other methods, the number of clusters must be specified
beforehand. Results can be seen in Fig. 16. Again, eight clusters separate the t-SNE data
nicely. The silhouette score is inapplicable in this case as it is not guaranteed to form
convex clusters.
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Agglomerative clustering with single and complete linkage
There are other linkage metrics that can be used with hierarchical clustering, like single
and complete. Single linkage allows merging of clusters based on the distance between
their two closest points and tends to optimize clusters defined by local proximity,
whereas complete linkage merges clusters based on the distance between their farthest
points and tends to optimize clusters for global proximity (52). Outliers are harshly
penalized in complete linkage. Both of these linkages were applied to the latent
representation of the data, and both produced essentially one giant cluster
encompassing all the data, with seven additional imperceptible clusters so small they
were not visible in the projections. For brevity, these figures are not shown here.

Fig. 16: PCA and t-SNE projection of agglomerative hierarchical clustering with ward linkage.

Density-Based Methods
DBSCAN
DBSCAN (Density-Based Spatial Clustering of Applications with Noise) is a clustering
algorithm which, as its name suggests, clusters not by distance as k-means does, but by
density. Briefly, it finds data points that meet a minimum threshold of having n
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neighbors within distance 𝜖, called core objects. It sequentially builds up clusters by
joining core objects if one is within distance 𝜖
of the other. The advantage of a density-based approach to clustering is that the
clusters need not be convex (52). One disadvantage is that both n and 𝜖 are userdefined, thus the potential search space is much greater than when searching for k
clusters with k-means. An additional noteworthy feature of the algorithm is that any
points outside a dense region will not become part of any cluster and will instead be
marked as outliers. Several iterations of DBSCAN with multiple hyperparameter settings
are shown in Fig. 17. The DBSCAN results interestingly bridge points across what seem
to be different clusters from visual inspection, suggesting that these points are actually
close by in the latent space. Not shown are the PCA projections, which
demonstrate that in all of these arrangements, half if not most of the points are
considered outliers. It demonstrates that the majority of the points in the latent space
are clustered tightly together towards on side of the first principal component as seen in
Fig. 9.

Fig. 17: DBSCAN clustering with three hyperparameter settings. From left to right: E=5, min_samples=100; E=5,
min_samples=1000; E=10, min_samples=1000. They arrived at 1 cluster, 2 clusters, and 1 cluster respectively. Black points are
outliers.
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Making Sense of the Clustering
Overall, the general pattern was that quantitative methods and projection by PCA did
not convincingly demonstrate distinct clusters. Interestingly, an eight-cluster
arrangement brought about the same separation in the t-SNE projection with both kmeans, k-medoids, and agglomerative hierarchical clustering with ward linkage. But one
must take the overall picture; if k-means and k-medoids clusters were high quality
clusters as they appear to be in the t-SNE projection, one would expect that the
quantitative methods, especially the silhouette score, would have shown more
promising results. While the gap statistic did recommend eight clusters, there was not a
significant drop in gap between eight and nine clusters, while the silhouette score
showed very strikingly the drop in average score from two clusters onwards. The
hypothesis that there are no clusters is also supported by the PCA projection along the
12 principal components in Fig. 9. Likewise, the density-based clustering supports the
notion that the t-SNE is misleading in that dense regions in a single cluster bridge the
apparent “clusters” shown in that projection. The DBSCAN results very much mirror
what one might expect looking at the PCA projection along the first 12 principal
components. Moreover, both complete- and single-linkage metrics used for hierarchical
agglomerative clustering created essentially one large cluster with seven imperceptible
small clusters.
To better illuminate possible differences in clusters, I examined the centroid example
for each cluster in the k-medoids clustering. I examined the 20 columns with the
greatest index of dispersion (𝜎 # /𝜇), along with their final disposition, and compared
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them in Table 4. Clusters 0, 3, and 6 (corresponding approximately to clusters 5, 6, and 0
in the k-means clustering with k=8; green, magenta, and blue in the agglomerative
clustering with k=8) correspond roughly to the major groupings seen in the t-SNE
projection. I was unable to discern salient differences except that all three are middle
aged or older, have higher creatinine, take more medications, and cluster 0 is centered
on an elderly person with a high white count with a neutrophilic predominance. The
centroids of clusters 0 and 3 were admitted while the rest were discharged. In Table 5, I
show the admission rates of these clusters. A chi-squared test did not find any
statistically significant difference in admission rate between them, with a test-statistic of
9.0 and a p=0.25. In summary, there is reasonable doubt as to whether these are,
indeed, distinct clusters with distinct differences. They do not differ significantly by
admission rate, although this may be because there are differences imperceptible to the
physicians making those decisions. This explanation is less likely however.
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Table 4: K-medoids centroids and variables with greatest dispersion.
A=admit, D=discharge

Variable

Cluster centroid
0

platelets

1

1118 207

2

3

4

278

229 207

5

6

7

348

226

207

age

92

38

24

43

54

21

58

32

num_meds

19

3

10

21

1

1

31

9

creatinine

2.4

0.7

0.7

1.5

0.7

0.6 13.1

0.7

bun

27

11

14

20

11

11

34

11

vitals_dbp__min

57

93

109

77

95

55

78

81

vitals_dbp__last

58

93

109

80

95

55

78

81

6

10

25

24

10

26

17

10

anc

19.5

4.8

5.6

3.7

4.8

6.7

4.6

4.8

vitals_dbp__mean

65.5

93 112.3 78.5

95 60.5

89 83.5

vitals_hr__first

106

98

100

72

81

64

72

75

vitals_dbp__first

76

93

114

77

95

66

106

86

vitals_dbp__max

76

93

114

80

95

66

106

86

vitals_sbp__last

123 135

159

154 155

105

128

132

wbc

21.4

8.4

8.4

6.5

8.4 10.6

6.6

8.4

93

98

81

70

81

64

62

75

123 135

154

131 155

105

128

129

lymphocytes

vitals_hr__min
vitals_sbp__min
vitals_o2_amount__max

2

0

0

0

0

0

0

0

vitals_o2_amount__last

2

0

0

0

0

0

0

0

monocytes

3

7

6

16

7

7

11

7

Disposition

A

D

D

A

D

D

D

D
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Table 5: Admission rate by cluster
Cluster Admit rate (%)
0

42.43

1

40.31

2

39.92

3

39.95

4

39.61

5

39.79

6

39.89

7

39.90

In summary, based upon these data, it does not appear that there are salient clusters.
Though this thesis has attempted to perform a thorough search with multiple
techniques, many more remain to be tested. So, while I cannot conclusively determine
that no clusters exist (with enough data and the right representation, they probably do),
these results reasonably demonstrate that no obvious clusters exist.

Limitations and Advantages
There several key limitations to this study. First, the dataset is a highly heterogeneous
clinical dataset with a significant amount of missing data (see Table 6 in Appendix A).
While it is commonplace in real-world clinical datasets, missing data provides a serious
challenge to machine learning algorithms that learn relationships between different
variables because new relationships (i.e. bias) can be introduced through the process of
imputation. In clinical data, missing data is usually not missing not at random. In other
words, there is information in the fact that the data is missing; a physician might not
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have ordered a laboratory test because she did not anticipate that the value would be
abnormal. In this manner, physician insight leaks into the dataset. Then, one must
decide how to impute the missing values. As discussed in the methods section, mean
imputation introduces problems when the data do lie in a normal distribution. In this
thesis, I tried to mitigate these influences by imputing the column mode for each value,
and by introducing an “is missing” variable for each variable. The intention is that the
autoencoder would come to learn the relationship between the mode of a variable and
the presence of the missing flag, thus discounting its reliance on this value for
prediction. There is evidence that the autoencoder did learn well considering the
reconstruction error compared to PCA. State of the art imputation methods use other
machine learning techniques, like a Random Forest classifier or regressor to impute
missing values by learning from data where that value is not missing. Though this
approach is vulnerable to data missing not at random, it may provide better
performance for this model in the future. In this thesis, it could not be employed due to
technical issues.
Another limitation of this thesis is the interpretability of the autoencoder latent
representation. Because an autoencoder learns a non-linear mapping of the original
data to the latent space, it is very difficult to discern the significance of the original
variables in the latent representation as one could with PCA. Inspection of cluster
differences based upon the medoids shows some differences, but despite this the
overall admission rate was unchanged between clusters. Further analysis will be needed
to understand any differences between these putative clusters.
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A third limitation is the representation of the data for training by the autoencoder.
Because binary and continuous variables were treated equivalently, with the training
minimizing the mean squared error between the original data and its reconstruction, it
is possible that the binary variables overwhelmingly dominated the loss function and the
encoder was not forced to learn a good representation of the continuous variables. This
could potentially be mitigated in future work by building an autoencoder with two
output layers, one for continuous variables and one for binary variables, which are
trained together but with different loss functions (mean squared error and crossentropy, respectively) which are then combined in a weighted sum to produce an
overall loss function.
Overall, there are several advantages of the approach taken in this thesis. By not
including physician notes as other EHR deep learning has (39), this approach reduces the
potential for physician bias to leak into the data. Moreover, the use of an autoencoder
enables the discovery of highly abstract features and non-linear relationships that would
not be apparent with the traditional regression techniques used in the seminal sepsis
definition papers (19). It also obviates the need for feature selection, thereby enabling
the discovery of new important features that may have previously been overlooked.

Conclusions
This thesis sought to characterize phenotypes of infection amongst potentially septic
patients in the emergency department through a variety of unsupervised machine
learning techniques. I created an autoencoder, a type of deep learning architecture, to
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reduce the dimensionality of the electronic health record data. The reconstruction error
of this reduction compared very favorably to PCA, suggesting the latent representation
had captured salient abstract features of the dataset. When clustering, however, results
were not as clear. The sum of evidence did not point to distinct clusters. If the 8 putative
clusters identified by several methods are indeed real, there was no difference in
admission rate amongst them suggesting any differences may not be salient enough to
produce a clinical effect (or that physicians are not noticing the differences). The
implication of this lack of clusters is significant for clinical care, and was articulated
clearly by Knaus et al. in 1992 (22):
“Sepsis is a complex clinical entity and could be viewed as a continuum
with substantial variation in initial severity and risk of hospital death. One
accurate description of sepsis is the continuous measure of hospital
mortality risk estimated primarily from physiologic abnormalities… These
findings led us to our major conclusion that while categoric definitions of
sepsis may be useful in selecting patients for entry into clinical trials, they
may not be useful in characterizing individual, or perhaps even group, risks.
What our results suggest rather is that the current clinical condition of
sepsis, at least as it is applied to a subset of critically ill patients admitted
to ICUs, is a continuous state with the prognosis determined, in large part,
by the degree of physiologic imbalance at the time of admission.”
If potentially septic patients were scored directly with a continuous mortality
prediction tool, that might better inform their management. Categorization by
bedside rules is helpful when a clinical condition can be reduced to such a
scoring system, but it is unreasonable to expect that something as complex as
pathophysiology can always be summarized with an easily-memorized rule,
despite what Vincent et al. have argued (10). With the advent of EHRs and
increasing computing power, complex models can potentially be included in the
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physician workflow without added effort. One can even imagine these prediction
tools running on all patients and only alerting a physician when mortality
prediction reaches a certain threshold. This would spare the debate over what
category a patient falls into for the time being. In the future, a better
pathophysiological understanding of sepsis may make this categorization
possible, but for now it may be best for patients to wait until then to use
categorical classification with sepsis.
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Appendix
Table 6: Retained variables and % missing
Variable

%
missing Variable

%
missing

ethnicity

0.0

medtype_BIOLOGICALS

19.2

gender

0.0

19.2

age

0.0

medtype_PSYCHOTHERAPEUTIC
DRUGS
medtype_PRE-NATAL VITAMINS

vitals_hr__max

0.2

medtype_MUSCLE RELAXANTS

19.2

vitals_hr__min

0.2

medtype_ANTIDOTES

19.2

vitals_hr__mean

0.2

19.2

vitals_hr__last

0.2

medtype_MISCELLANEOUS MEDICAL
SUPPLIES, DEVICES, NON-DRUG
medtype_INVESTIGATIONAL

vitals_hr__first

0.2

medtype_IMMUNOSUPPRESANT

19.2

vitals_sbp__first

0.3

medtype_HORMONES

19.2

vitals_sbp__last

0.3

medtype_HERBALS

19.2

vitals_sbp__mean

0.3

medtype_CARDIAC DRUGS

19.2

vitals_sbp__min

0.3

medtype_CARDIOVASCULAR

19.2

vitals_sbp__max

0.3

medtype_GASTROINTESTINAL

19.2

vitals_dbp__last

0.3

medtype_ELECT/CALORIC/H2O

19.2

vitals_dbp__mean

0.3

medtype_CNS DRUGS

19.2

vitals_dbp__min

0.3

19.2

vitals_dbp__first

0.3

medtype_COLONY STIMULATING
FACTORS
medtype_EENT PREPS

vitals_dbp__max

0.3

medtype_DIURETICS

19.2

vitals_o2_sat__first

0.4

medtype_DIAGNOSTIC

19.2

vitals_o2_sat__max

0.4

medtype_BLOOD

19.2

vitals_o2_sat__last

0.4

medtype_ANALGESICS

19.2

vitals_o2_sat__mean

0.4

19.2

vitals_o2_sat__min

0.4

vitals_rr__max

0.6

medtype_COUGH/COLD
PREPARATIONS
medtype_ANTIHISTAMINE AND
DECONGESTANT COMBINATION
medtype_ANTIARTHRITICS

vitals_rr__first

0.6

medtype_ANTIASTHMATICS

19.2

vitals_rr__last

0.6

medtype_ANESTHETICS

19.2

vitals_rr__min

0.6

medtype_ANTIBIOTICS

19.2

19.2

19.2

19.2

19.2
19.2
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vitals_rr__mean

0.6

medtype_ANTIHYPERGLYCEMICS

19.2

vitals_temp__max

1.5

medtype_ANTIINFECTIVES

19.2

vitals_temp__first

1.5

medtype_ANTIHISTAMINES

19.2

vitals_temp__last

1.5

vitals_temp__min

1.5

medtype_ANTIINFECTIVES/MISCELLAN 19.2
EOUS
medtype_CONTRACEPTIVES
19.2

vitals_temp__mean

1.5

medtype_ANTIPARKINSON DRUGS

19.2

altered

3.0

medtype_ANTIFUNGALS

19.2

vitals_o2_dependency__mean

4.3

medtype_ANTIPLATELET DRUGS

19.2

vitals_o2_dependency__max

4.3

medtype_ANTI-OBESITY DRUGS

19.2

vitals_o2_dependency__first

4.3

medtype_ANTICOAGULANTS

19.2

vitals_o2_dependency__last

4.3

medtype_ANTINEOPLASTICS

19.2

vitals_o2_dependency__min

4.3

rdw

41.5

vitals_o2_amount__max

5.0

wbc

41.5

vitals_o2_amount__first

5.0

hematocrit

41.5

vitals_o2_amount__last

5.0

mcv

41.5

vitals_o2_amount__min

5.0

mpv

41.5

vitals_o2_amount__mean

5.0

hemoglobin

41.5

use_etoh

5.1

rbc

41.5

use_illicit

5.1

platelets

41.5

smoking

5.3

mchc

41.5

pmh_arrhythmias

10.4

mch

41.5

pmh_cancer

10.4

anc

41.8

pmh_other_respiratory

10.4

lymphocytes

41.9

pmh_diabetes

10.4

absolute lymphocyte count

41.9

pmh_other_nutritional_endocrine_and_metab 10.4
olic_disorders
pmh_maintenance_chemotherapy_radiothera 10.4
py
pmh_chf
10.4

neutrophils

41.9

monocytes

42.0

eosinophils

42.0

pmh_liver_disease_alcohol_related

basophils

42.0

pmh_chronic_obstructive_pulmonary_disease 10.4
_and_bronchiectasis
pmh_immunity_disorders
10.4

calcium

43.8

chloride

43.8

pmh_hypertension_with_complications_and_s 10.4
econdary_hypertension
pmh_hiv_infection
10.4

sodium

43.8

co2

43.8

10.4
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pmh_heart_disease

10.4

anion gap

43.8

pmh_fen

10.4

bun

43.8

pmh_thyroid_disorders

10.4

creatinine

43.8

pmh_kidney_disease

10.4

glucose

43.8

pmh_asthma

10.4

potassium

44.8

medtype_ANALGESIC AND ANTIHISTAMINE 19.2
COMBINATION
num_meds
19.2

vitals_gcs__max

59.1

vitals_gcs__mean

59.1

medtype_ANTIVIRALS

19.2

vitals_gcs__last

59.1

medtype_VITAMINS

19.2

vitals_gcs__first

59.1

medtype_UNCLASSIFIED DRUG
PRODUCTS
medtype_THYROID PREPS

19.2

vitals_gcs__min

59.1

19.2

total bilirubin

72.0

medtype_SMOKING DETERRENTS

19.2

lactate

81.7

medtype_AUTONOMIC DRUGS

19.2

medtype_SKIN PREPS

19.2

medtype_SEDATIVE/HYPNOTICS

19.2

Table 7: Medication Type Categories
ANALGESIC AND ANTIHISTAMINE
COMBINATION

ANTIPARKINSON DRUGS

GASTROINTESTINAL

ANALGESICS
ANESTHETICS

ANTIPLATELET DRUGS
ANTIVIRALS

HERBALS
HORMONES

ANTI-OBESITY DRUGS

AUTONOMIC DRUGS

IMMUNOSUPPRESANT

ANTIARTHRITICS

BIOLOGICALS

ANTIASTHMATICS

BLOOD

INVESTIGATIONAL
MISCELLANEOUS MEDICAL
SUPPLIES, DEVICES, NON-DRUG

ANTIBIOTICS

CARDIAC DRUGS

MUSCLE RELAXANTS

ANTICOAGULANTS

CARDIOVASCULAR

PRE-NATAL VITAMINS

ANTIDOTES

CNS DRUGS

PSYCHOTHERAPEUTIC DRUGS

ANTIFUNGALS
ANTIHISTAMINE AND DECONGESTANT
COMBINATION
ANTIHISTAMINES

COLONY STIMULATING FACTORS

SEDATIVE/HYPNOTICS

CONTRACEPTIVES
COUGH/COLD PREPARATIONS

SKIN PREPS
SMOKING DETERRENTS

ANTIHYPERGLYCEMICS
ANTIINFECTIVES

DIAGNOSTIC
DIURETICS

THYROID PREPS
UNCLASSIFIED DRUG PRODUCTS

ANTIINFECTIVES/MISCELLANEOUS
ANTINEOPLASTICS

EENT PREPS
ELECT/CALORIC/H2O

VITAMINS
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